Therefore, plasma betatrophin may indirectly reflect the progression of NAFLD, namely NASH incidence, which was consistent with the findings from the study of Arias-Loste et al [23]. The gene discussed is ANGPTL8; the disease is metabolic dysfunction-associated steatohepatitis.